Acasti Pharma | ACST - Eigenkapital Und Reserven





Eigenkapital Und Reserven Veränderung Datum
Acasti Pharma USD 64.89M 2.07M 2025-12
Addus HomeCare USD 1.12B 30.86M 2026-03
Amarin USD 443.62M 5.8M 2026-06
Cassava Sciences USD 68.14M 6.26M 2026-03
Knight Therapeutics CAD 767.27M 480K 2025-12
Option Care Health USD 1.26B 91.17M 2026-06
Organigram Holdings CAD 371.81M 2.36M 2026-03
Tilray USD 1.58B 39.08M 2025-09